These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16898004)

  • 1. [S-1 monotherapy for pancreatic cancer].
    Okusaka T; Ueno H; Ikeda M; Morizane C
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():207-12. PubMed ID: 16898004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two patients effectively treated by S-1 monotherapy for metastatic pancreatic cancer].
    Ikeda M; Ueno H
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1515-9. PubMed ID: 17033250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy].
    Funakoshi A; Senju T; Sumii T
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1505-9. PubMed ID: 17033248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A late phase II study of S-1 for metastatic pancreatic cancer.
    Okusaka T; Funakoshi A; Furuse J; Boku N; Yamao K; Ohkawa S; Saito H
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):615-21. PubMed ID: 17520253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An early phase II study of S-1 in patients with metastatic pancreatic cancer.
    Ueno H; Okusaka T; Ikeda M; Takezako Y; Morizane C
    Oncology; 2005; 68(2-3):171-8. PubMed ID: 16006754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase I study of oral S-1 and concurrent radiotherapy in patients with unresectable locally advanced pancreatic cancer.
    Sudo K; Yamaguchi T; Ishihara T; Nakamura K; Shirai Y; Nakagawa A; Kawakami H; Uno T; Ito H; Saisho H
    Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):219-24. PubMed ID: 17189072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long term survival on S-1 monotherapy in a patient with recurrent stage IV pancreatic cancer.
    Alsamarai S; Zergebel C; Zhang J; Furuie T; Urrea PD; Saif MW
    JOP; 2008 Mar; 9(2):185-91. PubMed ID: 18326927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High response rates in patients with pancreatic cancer using the novel oral fluoropyrimidine S-1.
    Hayashi K; Imaizumi T; Uchida K; Kuramochi H; Takasaki K
    Oncol Rep; 2002; 9(6):1355-61. PubMed ID: 12375048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A late phase II clinical study of S-1 in patients with progressed, refractory breast cancer].
    Saeki T; Takashima S; Sano M; Horikoshi N; Miura S; Shimizu S; Morimoto K; Kimura M; Taguchi T
    Gan To Kagaku Ryoho; 2004 Apr; 31(4):539-47. PubMed ID: 15114697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter phase II trial of S-1 with concurrent radiation therapy for locally advanced pancreatic cancer.
    Ikeda M; Ioka T; Ito Y; Yonemoto N; Nagase M; Yamao K; Miyakawa H; Ishii H; Furuse J; Sato K; Sato T; Okusaka T
    Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):163-9. PubMed ID: 22677367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.
    Zhu AX; Clark JW; Ryan DP; Meyerhardt JA; Enzinger PC; Earle CC; Fuchs CS; Regan E; Anbe H; Houghton M; Zhang J; Urrea P; Kulke MH
    Cancer Chemother Pharmacol; 2007 Feb; 59(3):285-93. PubMed ID: 16786333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New oral anticancer drug, TS-1 (S-1)--from bench to clinic].
    Shirasaka T; Tsukuda M; Inuyama Y; Taguchi T
    Gan To Kagaku Ryoho; 2001 Jun; 28(6):855-64. PubMed ID: 11432358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phase II study of S-1, a novel oral fluorouracil, in advanced non-small-cell lung cancer].
    Yumine K; Kawahara M
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():189-92. PubMed ID: 16898000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase 2 trial of oral S-1 combined with low-dose cisplatin for unresectable advanced pancreatic cancer.
    Ina S; Tani M; Kawai M; Hirono S; Miyazawa M; Nishioka R; Fujita Y; Yamaue H
    Anticancer Res; 2008; 28(4C):2373-7. PubMed ID: 18751421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Resolution of liver metastases in response to S-1 monotherapy in advanced pancreatic cancer--a case report].
    Mizuno N; Sawaki A; Yamao K
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1511-4. PubMed ID: 17033249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical results of single therapy with TS-1 for advanced/recurrent gastric cancer].
    Ohshima T; Yamada R; Hatori S; Kunisaki C; Makino T; Yamazaki Y; Suda T; Rino Y; Takanashi Y; Imada T
    Gan To Kagaku Ryoho; 2006 Aug; 33(8):1105-10. PubMed ID: 16912529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical benefit of S-1 in metastatic breast cancer].
    Saeki T
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():202-6. PubMed ID: 16898003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II clinical study of alternate-day oral therapy with S-1 as first-line chemotherapy for locally advanced and metastatic pancreatic cancer.
    Yamaue H; Satoi S; Kanbe T; Miyazawa M; Tani M; Kawai M; Hirono S; Okada K; Yanagimoto H; Kwon AH; Mukouyama T; Tsunoda H; Chijiiwa K; Ohuchida J; Kato J; Ueda K; Yamaguchi T; Egawa S; Hayashi K; Shirasaka T
    Cancer Chemother Pharmacol; 2014 Jan; 73(1):97-102. PubMed ID: 24146260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early phase II study of S-1 in patients with advanced head and neck cancer. S-1 Cooperative Study Group (Head and Neck Working Group)].
    Inuyama Y; Kida A; Tsukuda M; Kohno N; Satake B
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1151-8. PubMed ID: 9679577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [S-1 combined with weekly dosing of cisplatin for metastatic gastric cancer].
    Hyodo I
    Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():64-7. PubMed ID: 16897974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.